Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Talis Biomedical Corp (TLIS)

Talis Biomedical Corp (TLIS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Talis Biomedical Corp 1375 WEST FULTON MARKET SUITE 700 CHICAGO IL 60607 USA

https://talisbio.com P: 650-433-3000

Description:

Talis Biomedical Corporation engaged in developing and commercializing products for infectious diseases at the point-of-care. The company involved in developing the Talis One platform, a compact, sample-to-answer, cloud-enabled, molecular diagnostic platform. Talis Biomedical Corporation is based in MENLO PARK, Calif.

Key Statistics

Overview:

Market Capitalization, $K 16,946
Enterprise Value, $K -59,784
Shares Outstanding, K 1,822
Annual Sales, $ 2,130 K
Annual Net Income, $ -62,010 K
Last Quarter Sales, $ 200 K
Last Quarter Net Income, $ -13,460 K
EBIT, $ -66,820 K
EBITDA, $ -66,050 K
60-Month Beta 1.66
% of Insider Shareholders 46.00%
% of Institutional Shareholders 43.77%
Float, K 984
% Float 54.00%
Short Volume Ratio 0.34

Growth:

1-Year Return 15.05%
3-Year Return -93.84%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -7.15 on 05/08/24
Latest Earnings Date 05/09/24
Earnings Per Share ttm -34.18
EPS Growth vs. Prev Qtr 3.25%
EPS Growth vs. Prev Year 27.74%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 07/06/23

TLIS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -75.40%
Return-on-Assets % -56.16%
Profit Margin % -2,911.27%
Debt/Equity 0.00
Price/Sales 7.91
Price/Cash Flow N/A
Price/Book 0.30
Book Value/Share 37.98
Interest Coverage -1.20
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar